Information For Authors
Submitting Your Manuscript
AIDS Research and Human Retroviruses welcomes format-neutral manuscripts for first-time submissions. Newly submitted manuscripts will not be un-submitted for formatting issues. However, after the initial peer review process, revised submissions must follow correct journal formatting and file guidelines, as described below in the Instructions for Authors. Please note that there are certain compulsory elements (ie: IRB approvals, author disclosures, etc.) for all new submissions. Manuscripts submitted without this information will be un-submitted and the submitting author will be asked to add the required components.
ORCID IDs
All submitting authors are required to complete their submissions using an ORCID identifier. Please visit the ORCID website for more information, or to register.
Use of English Language
All submissions must be in English. Appropriate use of English is a requirement for review and publication in AIDS Research and Human Retroviruses. To support non-native speakers, Mary Ann Liebert, Inc., has partnered with Editage to provide language editing and translation services for a fee prior to official submission. To learn more about the services, please visit the Liebert Author Services website. Please note that employing the use of such services is not mandatory and using it, or any other language editing service, does not guarantee the acceptance of any paper. All submissions are subject to peer review.
Manuscript Submission Site
CLICK HERE TO SUBMIT YOUR PAPER
See JOURNAL STANDARDS AND BEST PRACTICES STATEMENT
Check the Journal’s PEER REVIEW POLICIES
Manuscript Preparation
Determining Authorship
(See AUTHORSHIP DEFINITION AND RESPONSIBILITIES)
All authors, including the co-authors, should be responsible for a significant part of the manuscript. All authors and co-authors should have taken part in writing the manuscript, reviewing it, and revising its intellectual and technical content. Any author whose name appears on a paper assumes responsibility and accountability for the results.
Submission Process
CLICK HERE FOR ARTICLE TYPES AND WORD LIMITS
All Original submissions must contain:
An Internal Review Board (IRB) approval (or waiver) statement in the Methods section
Acknowledgments section (if applicable) after the Conclusion of the paper, followed by
Sequence Data / Accession Number(s) (if applilcable) followed by
An Author Contribution statement for each listed author, followed by
An Author Disclosure Statement for each author listed on a submission, even if there are no conflicts to disclose, followed by,
Funding statement(s), even if there is no funding information to declare.
See IRB APPROVALS, PATIENT CONSENT, & ETHICAL TREATMENT OF ANIMALS
See AUTHOR CONFIRMATION AND DISCLOSURE STATEMENTS
See FUNDING INFORMATION: COMPLIANCE AND STATEMENTS
Note: Just Accepted / Instant Online Publication
AIDS Research and Human Retroviruses publishes all accepted papers within 72 hours of receipt of all authors' signed copyright agreement forms in their unedited, uncorrected format.
It is important to note that the information that is published online, and in all indexing services, is pulled directly from the data that is populated into the fields in Manuscript Central – NOT from the manuscript file – when the paper is originally uploaded to the system for peer review. Consequently, any errors contained in the system will remain on our website and all indexing services, including Medline, until the next revision* of the article is published. As such, it is critical that authors enter all authors’ names correctly into the system at the time of submission. Any omissions or errors will remain on our website and in indexing services until the subsequent online version is published.
*The next revision will take place after the corresponding author reviews page proofs, makes any necessary corrections, and returns the changes to the Publisher. Once the alterations are completed, the revised version will be published on our website, and the newly corrected information will then be released to Medline/PubMed, in addition to any other indexing services in which the Journal is included.
Please note that the typical time between acceptance of a paper and page proof distribution is approximately 4 (four) weeks depending on the length and complexity of the paper.
Nomenclature
AIDS Research and Human Retroviruses has adopted the recommendations of the Executive Committee of the International Committee on Taxonomy of Viruses (ICTV) (Ref: Science 232:1486, 1986, and Nature 321:644, 1986) to designate viruses associated with AIDS. The Committee’s suggestion was to use HIV (human immunodeficiency virus) or the generic name for this class of human retroviruses. The Committee also recommended maintaining the specific strain names (LAV-1BRU, LAV-1LOI, HTLV-IIIB, HTLV-IIIRF, ARV1 . . .) in the interest of continuity and appreciation for the biologic and molecular differences of the individual strains. Thus, for the sake of accuracy, the editors encourage the use of specific strain names in experimental details.
Sequence Data
AIDS Research and Human Retroviruses requires submission of accession numbers with any manuscript that uses sequence data. The numbers must be listed in a separate section following Acknowledgments section. Accession numbers can be obtained from Genbank, EMBL, or DDBJ.
All manuscripts must be prepared in accordance with the Uniform Requirements for Manuscripts Submitted for Biomedical Journals.
When submitting your manuscript for peer review, be prepared to :
Enter the full title of the manuscript
Enter the full names and institutional affiliations of ALL listed authors
Enter ALL listed authors' institutional email addresses
Identify the corresponding author
Enter a running (abbreviated) title of no more than 50 characters (including spaces).
Enter 3–5 keywords or phrases.
Provide a structured abstract of no more than 250 words, stating the background, methods, and results (including the sample size), drawn from the study.
Provide the names and email addresses of at least five potential preferred reviewers familiar with the field. Please make sure preferred reviewers are not from your university or institution or with whom you have collaborated. Anyone whom the author does not want to be considered should also be named as a non-preferred reviewer. Ultimate reviewer selection is at the Editor’s discretion.
Confirm that the material has not been published or submitted for publication elsewhere.
File Naming
All file names should be in English and contain only alphanumeric charachters. Do not include spaces, sybmols, special characters, dashes, dots, or underscores. Label each file with the first author's last name, followed by the content of the file (ie: SmithText; SmithTables; SmithFigureLegends; SmithFig1, etc)
Important: Please upload individual files of all manuscript material as described herein — please do NOT upload a combined PDF file containing all material in your submission.
Preparation of Manuscript
Prepare text of manuscripts, figure legends, and tables in Microsoft Word, double spaced. The order of elements in each manuscript should be:
Title page (with full manuscript title, all contributing authors and their affiliations, a short running title, a denotation of the corresponding author, and a list of 3-6 keywords
Abstract
Main text (do not embed figures or tables)
Conclusion (as a separate paragraph, not as part of the Discussion section)
Acknowledgments (if applicable)
Sequence Data / Accession Number(s)
Authorship confirmation statement (see below)
Author(s’) disclosure statement(s) (see below)
Funding statement (see below)
References
Figure legends
Tables
Supplemental files (if applicable. If the submission is accepted, Supplemental Information will NOT be published in the Just Accepted/LION platform, but instead will be published in the Online Now (epub) and final versions of the article. Supplemental Information will not be copyedited or typeset; it will be posted online as supplied.)
Manuscript Text
Maximum word count should not exceed 4,000 words. In general, the text should be organized under the headings: Introduction, Materials and Methods, Results, Discussion, and Conclusions. Use only standard abbreviations, which can be found in the AMA’s Manual for Authors & Editors or the Council of Biology Editors Style Manual, 10/e. At first usage, spell out terms and provide abbreviations in parentheses. Thereafter, use only the abbreviations. It is not necessary to spell out standard units of measure. Use generic names for drugs if possible. If you wish to use a proprietary drug name the first time it appears, use the generic name followed by the proprietary name, manufacturer, and location in parentheses.
References
References must be prepared in word, double spaced, and numbered consecutively as they are cited in the text (using superscript numbers). Include reference section as part of the main text file, not as aseparate file. References appearing for the first time in tables and figures must be numbered in sequence with those cited in the text where the table or figure is mentioned. Use journal abbreviations as provided by PubMed/Medline. List all authors when there are six or less. When there are more than six, list the first three, followed by et al. If references to personal communications or unpublished data are used, they are not to be in the list of references. They should be referred to in the text in parentheses: (AB Jones, personal communication). Include among the references any papers that have been accepted but have not yet published; identify the name of publication and add "In Press." If the reference has been published online, provide the DOI number in place of the page range.
Sample style for references:
Journal article:
Hendrix CW,Andrade A, Bumpus NN, Kashuba AD, Marzinke MA, Moore A et al. Dose frequency ranging pharmacokinetic study of tenofovir-emtricitabine after directly observed dosing in healthy volunteers to establish adherence benchmarks (HPTN 066). AIDS Res Hum Retroviruses 2015;32(1):32-43.
Book:
Vicenzi E, Poli G. Human Retroviruses: Methods and Protocols (Methods in Molecular Biology). Totowa, NJ: Human Press (Springer) 2014.
Chapter in a book:
Cimarelli A, Darlix J-L. HIV-1 Reverse transcription. In: Human Retroviruses: Methods and Protocols (Methods in Molecular Biology), (Vicenzi E, Poli G.,eds.) Totowa, NJ: Human Press (Springer) 2014; pp. 55-70.
Legends
Figure legends should be uploaded as a separate Word file and double spaced. In the legend, provide explanations for any abbreviations, arrows, etc. that appear in the figure. If the illustration is taken from a copyrighted publication, permission must be secured, appropriate credit must be given in the legend, and a corresponding reference must appear in the reference section.
Tables
All tables should be prepared in one single Word file. Provide a title for each table. Cite tables in sequence in the text. Explain abbreviations used in the body of the table in footnotes. If the table is taken from a copyrighted publication, permission must be secured, appropriate credit must be given in the legend, and a corresponding reference must appear in the reference section.
Figures
Submission of high resolution .TIFF or .EPS figure files is strongly recommended.
Figures should not be embedded within the manuscript file.
Cite figures consecutively in text within parentheses.
A legend should be supplied for each figure and all legends numbered consecutively.
Images should not show the name of a patient or a manufacturer.
Do not include any illustrations as part of your text file.
Correspondence Address
Following the references, provide the name and complete affiliation and eamil address of the person to whom correspondence should be sent.
Manuscript Revisions
To upload a revision of a paper, the submitting author should log in to their Author Center at http://mc.manuscriptcentral.com/aidsresearch and click on “Revised Manuscripts in Draft.” All revised submissions will be required to meet all formatting conditions described herein. Submissions that do not satisfy these requirements will be un-submitted and returned to the submitting author for proper configuration.
Letters to the Editor
AIDS Research and Human Retroviruses will consider Letters to the Editor commenting on the scientific content of an article published in the Journal. Letters should not exceed 400-500 words of text and 5 references. Letters submitted for publication must be original and must not be submitted to any other publication simultaneousl
For questions regarding manuscript submissions, contact our Author Services Division.
